These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 7775601)

  • 21. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
    Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperactive autocrine loop mediated by a NDF-related factor in neoplastic hamster embryo fibroblasts expressing an activated cph oncogene.
    Avila MA; Velasco JA; Cho C; Lupu R; Wen D; Notario V
    Oncogene; 1995 Mar; 10(5):963-71. PubMed ID: 7534900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
    Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
    Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA; Mehmi I; Lupu R
    Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M; Grijalva R; Yu D
    Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells.
    Martínez-Lacaci I; De Santis M; Kannan S; Bianco C; Kim N; Wallace-Jones B; Wechselberger C; Ebert AD; Salomon DS
    J Cell Physiol; 2001 Feb; 186(2):233-42. PubMed ID: 11169460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y; Lin H; Zhu Y; Ma C; Ye J; Luo J
    J Cell Physiol; 2002 Aug; 192(2):225-33. PubMed ID: 12115729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors.
    Merlo GR; Graus-Porta D; Cella N; Marte BM; Taverna D; Hynes NE
    Eur J Cell Biol; 1996 Jun; 70(2):97-105. PubMed ID: 8793381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds.
    Danilenko DM; Ring BD; Lu JZ; Tarpley JE; Chang D; Liu N; Wen D; Pierce GF
    J Clin Invest; 1995 Feb; 95(2):842-51. PubMed ID: 7860768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells.
    Hamburger AW; Yoo JY
    Anticancer Res; 1997; 17(3C):2197-200. PubMed ID: 9216687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli.
    Jones FE; Jerry DJ; Guarino BC; Andrews GC; Stern DF
    Cell Growth Differ; 1996 Aug; 7(8):1031-8. PubMed ID: 8853899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells.
    Ethier SP; Moorthy R; Dilts CA
    Cell Growth Differ; 1991 Nov; 2(11):593-602. PubMed ID: 1726054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture.
    Strange KS; Wilkinson D; Edin G; Emerman JT
    Breast Cancer Res Treat; 2004 Mar; 84(2):77-84. PubMed ID: 14999138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.